Medicine guide
LOXAPAC
As listed in the register: LOXAPAC 50 mg/2 ml, solution injectable en ampoule (IM)
50 mg · solution injectable
- Prescription only
- Active substance
- Loxapine Base
- Made by
- CNX THERAPEUTICS FRANCE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | CNX THERAPEUTICS FRANCE |
|---|---|
| Active substance | Loxapine Base |
| Strength | 50 mg |
| Form | solution injectable |
| Route | intramusculaire |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · réservé à l'usage en situation d'urgence selon l'article R5121-96 du code de la santé publique · liste I · réservé à une structure d'assistance médicale mobile ou de rapatriement sanitaire |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | LOXAPAC 50 mg/2 ml, solution injectable en ampoule (IM) |
| Packs | 10 ampoule(s) de 2 ml |
| CIS | 69485940 |
| CIP13 | 3400956330980 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.